Micreos retweeted
“How we respond as a #pharmaceutical industry to this global crisis of #antimicrobialresistance is critical,” says @Micreos Pharmaceuticals CEO Matt Regan. Learn how Micreos is innovating beyond #antibiotics with novel technology https://teapawt.org/t.co/tv6xSxwWf3 #AMR
We are delighted to announce two new additions to the Micreos Pharmaceuticals Team: Trine Ahlgreen + Carsten Edwards. These key hires at the executive level will help us in our continued fight against Anti-Microbial Resistance (#AMR)!
businesswire.com/news/home/2…
1
1
Interesting interview with microbiologist Bjorn Herpers on Dutch #BNR News Radio! Learn more about MICREOS's Endolysin Technology / Staphefekt™ and Gladskin #eczema study results. #endolysins #MRSA
bnr.nl/player/audio/10216802…
We‘re happy to announce that Matt Regan has joined Micreos to run our new Pharmaceutical business! Welcome on board Matt!
prnewswire.co.uk/news-releas…
1
4
We’re excited to share that we’ve raised another €32 million to continue our research into endolysin-based alternatives to antibiotics. This will allow us to further our research into solutions for #atopicDermatitis,#sepsis, diabetic wounds and cancer.
prnewswire.co.uk/news-releas…
Happy to announce L’Oréal signed a license agreement with Micreos. Looking forward to helping millions of people with skin conditions and to accelerating our targeted and microbiome-based endolysin- technology.
mediaroom.loreal.com/wp-cont…
Research is continuing to provide evidence that our technology will change the way inflammatory skin conditions, like #eczema, are treated. Promising news for the milllions of people who are affected by these skin conditions world wide.
manchester.ac.uk/discover/ne…
It’s the first time an #endolysin under pharmaceutical development is being used in a clinical trial for #atopicdermatitis and the results could completely change current standard of care. Read more about our clinical trial with endolysin XZ.700: micreos.com/news/Micreos-ini…
Important read about how superbugs will complicate the care of many #COVID19 patients.
statnews.com/2020/03/23/ant…
#amr #endolysins #AntibioticResistance
#AMR contributes to the risk of novel deadly microbes spreading into human populations. And we experience on a daily basis, what happens, when treatment options lack. All this forces us to break with the old and imagine our world anew.
We are ready
vimeo.com/405387932
2
#AntimicrobialResistance
makes foodborne infections harder to treat. Phages can help to solve the problem, but it’s about time for a specific regulation!
europa.eu/!bU79uq
Read about our technology here:
Jumbovirussen zijn vijanden van bacteriën – en meer nrc.nl/nieuws/2020/02/25/jum…
#AMR #phages #endolysin #innovation
We‘re hiring!
✅Want to join a fast-growing company?
✅Want to be part of a young, enthusiastic team?
✅ Want to help to develop the world's first targeted antibacterial products, set to replace antibiotics?
Apply!
#HiringNow #phages #phagetechnology
bcfcareer.nl/vacancies/vacan…
🎊🍾Gladskin Launches in USA - Micreos Scaling up
finanznachrichten.de/nachric…
#endolysins #AMR #Staphefekt #AntibioticResistance #dermatology #neurodermitis #eczema
New report: Every 15 minutes, someone in the US dies of a drug-resistant superbug. No time to lose, no need to wait! #AMR #AntibioticResistance #superbugs #endolysins
Antibiotic resistance is a serious threat in the U.S. and globally. @CDCgov released an updated Antibiotic Resistance Threats Report detailing current AR threats in the U.S., challenges ahead and progress to date. Learn more: skyw.io/og3IGB #ASMAdvocacy #CDCARthreats
🇪🇺EU promotes Endolysin Technology, Set to Replace Antibiotics: Micreos Awarded €2.5 Million for Breakthrough for Skin Problems Including Acne and Eczema wallstreet-online.de/nachric… #AMR #AntibioticResistance #eczema
European Court of Justice paves the road for natural #phages against #listeria #FoodSafety medium.com/@Micreos/micreos-…






